Gate Neurosciences is a healthcare company that offers neuroscience-related medical services.
Gate Neurosciences has raised $25.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2022.
Gate Neurosciences's investors include BioCrossroads, Innoviva, Thornapple River Capital, Luson Bioventures.
Gate Neurosciences is headquartered in Carmel, United States.
Gate Neurosciences is a healthcare company that offers neuroscience-related medical services.
Gate Neurosciences is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Gate Neurosciences — Funding & Investors." VCBacked, October 5, 2022, https://www.vcbacked.co/company/gate-neurosciences. Accessed September 30, 2026.
VCBacked. (2022). Gate Neurosciences — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/gate-neurosciences
{{cite web |title=Gate Neurosciences — Funding & Investors |url=https://www.vcbacked.co/company/gate-neurosciences |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated